ADDvise receives order worth USD 1.4 million
Axelerist, an ADDvise Group company, has received an order from Vertex Pharmaceuticals, a global biotechnology company, for the sale and rental of medical and laboratory equipment. The order value amounts to USD 1.4 million. Delivery will take place over a four-year period starting in Q3 2024. For further information, please contact: Rikard Akhtarzand, CEO +46 (0) 76-525 90 71 rikard.akhtarzand@addvisegroup.se Important information This information is such that ADDvise Group AB (publ) is obliged to disclose pursuant to the EU Market Abuse Regulation. The